Cargando…
Transporter and metabolizer gene polymorphisms affect fluoroquinolone pharmacokinetic parameters
Tuberculosis (TB) is an infectious disease that occurs globally. Treatment of TB has been hindered by problems with multidrug-resistant strains (MDR-TB). Fluoroquinolones are one of the main drugs used for the treatment of MDR-TB. The success of therapy can be influenced by genetic factors and their...
Autores principales: | Annisa, Nurul, Barliana, Melisa I., Santoso, Prayudi, Ruslami, Rovina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798452/ https://www.ncbi.nlm.nih.gov/pubmed/36588725 http://dx.doi.org/10.3389/fphar.2022.1063413 |
Ejemplares similares
-
Genetic polymorphism related to ethambutol outcomes and susceptibility to toxicity
por: Barliana, Melisa Intan, et al.
Publicado: (2023) -
Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
por: Oehadian, Amaylia, et al.
Publicado: (2022) -
Anemia with elevation of growth differentiation factor-15 level in linezolid treated multidrug-resistant tuberculosis: Case series of three patients
por: Oehadian, Amaylia, et al.
Publicado: (2022) -
Genetic Polymorphisms and the Clinical Response to Systemic Lupus Erythematosus Treatment Towards Personalized Medicine
por: Barliana, Melisa Intan, et al.
Publicado: (2022) -
Between Curing and Torturing: Burden of Adverse Reaction in Drug-Resistant Tuberculosis Therapy
por: Ausi, Yudisia, et al.
Publicado: (2021)